Shamrock Gets FDA Warning for Mislabeling Drug Strength Published: Jun 28, 2012 The FDA has sent contract repackager Shamrock Medical a warning letter for labelling drugs with the wrong strength. Related links Outsourcing-Pharma.com This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news